Dr. Ali Mazhar Elkharbotly, MD

Dr. Elkharbotly practices at Ascension Medical Group Via Christi On Murdock in Wichita, Kansas.

Dr. Elkharbotly's NPI, 1710147780, was assigned on June 13, 2008. Dr. Elkharbotly holds Kansas license 04-37653.

Dr. Elkharbotly's primary practice is Ascension Medical Group Via Christi on Murdock, at 9211 E 21st N St, Wichita, KS 67206 in Sedgwick County. The practice phone is (316) 689-9135.

Dr. Elkharbotly's primary practice is Ascension Medical Group Via Christi On Murdock in Wichita, Kansas. Dr. Elkharbotly is also affiliated with Ascension Via Christi St. Francis. The medical group on file is Ascension Medical Group Via Christi on Murdock. Dmand AI also links Dr. Elkharbotly to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elkharbotly practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Elkharbotly's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Elkharbotly is licensed in Kansas.

CMS data shows 3,679 Medicare services from Dr. Elkharbotly across 24 procedure codes in 2024, for 1,045 Medicare patients. Medicare paid $230,162 for them.

CMS counts 1,045 Medicare patients who saw Dr. Elkharbotly in 2024. The largest group is 65 to 74, with 478 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Elkharbotly's median patient age at 70, with 49% women.

In 2024, Dr. Elkharbotly wrote 6,189 Medicare Part D claims for 798 patients. 88% of them were for generic drugs. CMS names the drug for 6,015 of them, across 49 drugs with 11 or more claims each, at $774,777 in total drug cost. In 2023, CMS named 5,590 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Elkharbotly for performance year 2024, reported as part of a group. Dr. Elkharbotly accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Elkharbotly, published from 2015 to 2023. 2023 was the busiest year, with 2. Dr. Elkharbotly has published most often in Cureus. Dr. Elkharbotly's most frequent co-authors are Zaher Fanari, MD and Mohammad Chafic El-Hajjar, MD.

CMS Open Payments shows 157 general payments to Dr. Elkharbotly from 22 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 69% of the total. Abiomed paid the most, $1,649.